This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...
(MENAFN- 3BL) June 8, 2026 /3BL/ - Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its NellcorTM pulse oximetry system with Nell-EQTM intelligent processor. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results